KYMR   $49.03  5.58% Market Closed After Close 49.184603 0.32%

Kymera Therapeutics Inc
Total Cash 509.95M
totalCashPerShare 8.258
EBITDA -176.97M
Total Debt 88.18M
quickRatio 8.234
currentRatio 8.455
Total Revenue 88.55M
debtToEquity 12.875
Revenue/Share 1.358
ROA -0.16038
ROE -0.28179002
grossProfits
freeCashflow -89.48M
operatingCashflow -106.13M
earningsGrowth
revenueGrowth 0.553
grossMargins -1.36147
ebitdaMargins -1.9985001
operatingMargins -1.9853799
profitMargins -1.78265
enterpriseValue 2.42B
forwardPE -14.54955
floatShares 41.63M
sharesOutstanding 64.58M
sharesShort 9.35M
sharesShortPriorMonth 9.85M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.06%
Short Ratio help_outline 20.49%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 11.124
Price To Book help_outline 4.36
earningsQuarterlyGrowth
netIncomeToCommon -157.85M
trailingEps -2.41%
forwardEps -3.33%
enterpriseToEbitda -13.70
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.84 3Q 2024
institutionsCount 236
lastUpdated Sept. 16, 2024, 8 p.m.